Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Researchers decipher modus operandi of potential Alzheimer’s drug

20.02.2013
The chemical compound known as “methylene blue” is a potential candidate for treating Alzheimer’s, as it prevents the harmful clumping of so-called tau proteins typically associated with this disease. However, until now it was unknown why methylene blue had this effect.

Researchers from Göttingen and Bonn have now shed light on this microscopic process. The study published in “Angewandte Chemie” might help to work out strategies for developing potential drugs. As the team of scientist including Markus Zweckstetter and Eckhard Mandelkow report, methylene blue inactivates molecular residues that promote the bonding of tau proteins.

Methylene blue is a multi-talented substance with a long history. The synthetic compound was first produced in 1876, and since then has served not only as a blue dye, but also as a medical drug – for example to treat malaria and prevent urinary tract infections. It is now also being debated as a potential treatment for Alzheimer’s disease.

Methylene blue works in many ways. With regard to Alzheimer’s, it is interesting to note that it prevents the clumping of “tau proteins”. Such aggregates are typical in numerous forms of dementia: The protein clumps accumulate in the brain cells, disrupt their function, and can even kill them.

“Tau proteins are actually extremely important, because they stabilize the transport routes inside each nerve cell,” explains Prof. Eckhard Mandelkow, who works at the German Center for Neurodegenerative Diseases (DZNE) and the caesar research center in Bonn. “However, in cases of Alzheimer’s, they stop doing their job. The transport routes inside the cells break down, and supplies essential for the survival of the cells can no longer reach their destination. In addition, the tau proteins stick together. These aggregates are also harmful and are a typical characteristic of the disease.”

Such characteristics can be reproduced in animal studies. Previously, another team of scientists led by Dr. Eva-Maria Mandelkow was able to prove that methylene blue is able to alleviate the symptoms of an illness in mice and threadworms. However, no significant data from human patients has been collected so far. Furthermore, to date it was unknown, why methylene blue had the observed effect. “Methylene blue inhibits the aggregation process,” Eckhard Mandelkow emphasizes. “But the way in which this happens was unknown until now.”

The study now published in “Angewandte Chemie“ reveals the nature of this process: Markus Zweckstetter’s research group at the DZNE site in Göttingen and the Max Planck Institute for Biophysical Chemistry in Göttingen in collaboration with the Mandelkow team have been able to prove that methylene blue deactivates molecular residues which promote the bonding of tau proteins. Moreover, the researchers found indications that the substance acts as a spacer to keep the proteins apart. These findings could lead to the development of modified forms of methylene blue and new types of treatment.

Background:
Methylene blue tackles sulphur groups
NMR spectroscopy, a powerful technique for investigating biomolecules, was centrally important to the current study. “We found that methylene blue reacts with certain elements in the tau proteins called cysteines,” Prof. Zweckstetter summarizes.

This reaction is highly effective. Methylene blue specifically modifies the tau proteins at critical spots: Of the up to 441 elements which a tau protein can consist of particularly the two cysteines are modified. The elements directly modified are the so-called SH groups, molecular appendages comprising sulphur and hydrogen which are typical of cysteines. Oxygen atoms now couple with them.

“This chemical transformation prevents tau proteins from bonding together,” says Zweckstetter. “Otherwise SH groups from different proteins would react and form a so-called disulfide bridge. Now, this is no longer possible, because the reaction with methylene blue eliminates the SH groups.”

In a healthy organism, the formation of these disulfide bridges is suppressed naturally. “The cell tries to prevent harmful reactions with the help of antioxidants,” says Eckhard Mandelkow. “However, with age and in cases of neurodegenerative diseases such as Alzheimer’s, this protective system weakens allowing tau proteins to aggregate.”

Beta sheets also important

Zweckstetter stresses that along with the disulfide bridges, another mechanism is important for the clumping of tau proteins. “Tau proteins aggregate particularly quickly when disulfide bonds form. These work like a trigger. However, tau proteins can also aggregate without these bridges, albeit more slowly.”

This is due to the structure of the molecule, the backbone of which can fold like an accordion in some places. Such regions can pile up to “beta sheets” when two proteins come together closely enough and in the appropriate orientation. “Our experiments also show a distinct effect of methylene blue on the regions that want to form these beta sheets.” Thus, methylene blue, particularly its derivatives “Azure A” and “Azure B”, which are expected to be predominantly present in the body, also appear to inhibit the aggregation of beta sheets. “Steric hindrance occurs,” Zweckstetter guesses. “When an inhibitor attaches to a beta sheet region of the tau protein, no other tau molecule can lock on.”

There are other substances besides methylene blue that can suppress the aggregation of tau proteins. Some of them focus explicitly on preventing the build-up of beta sheets. The researchers believe that an effective treatment could ultimately require a combination of various substances: “Certainly, one conclusion of our study is that there are different ways to disrupt the pathogenic aggregation of tau proteins.”

Original Publication
„Mechanistic Basis of Phenothiazine-driven Inhibition of Tau Aggregation“, Elias Akoury, Marcus Pickhardt, Michal Gajda, Jacek Biernat, Eckhard Mandelkow, Markus Zweckstetter, Angewandte Chemie, DOI: 10.1002/anie.201208290

http://onlinelibrary.wiley.com/doi/10.1002/anie.201208290/abstract

The German Center for Neurodegenerative Diseases (DZNE) investigates the causes of diseases of the nervous system and develops strategies for prevention, treatment and care. It is an institution of the Helmholtz Association of German Research Centres with sites in Berlin, Bonn, Dresden, Göttingen, Magdeburg, Munich, Rostock/Greifswald, Tübingen and Witten.

Dr. Marcus Neitzert | idw
Further information:
http://www.dzne.de/en

More articles from Life Sciences:

nachricht At last, butterflies get a bigger, better evolutionary tree
16.02.2018 | Florida Museum of Natural History

nachricht New treatment strategies for chronic kidney disease from the animal kingdom
16.02.2018 | Veterinärmedizinische Universität Wien

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Demonstration of a single molecule piezoelectric effect

Breakthrough provides a new concept of the design of molecular motors, sensors and electricity generators at nanoscale

Researchers from the Institute of Organic Chemistry and Biochemistry of the CAS (IOCB Prague), Institute of Physics of the CAS (IP CAS) and Palacký University...

Im Focus: Hybrid optics bring color imaging using ultrathin metalenses into focus

For photographers and scientists, lenses are lifesavers. They reflect and refract light, making possible the imaging systems that drive discovery through the microscope and preserve history through cameras.

But today's glass-based lenses are bulky and resist miniaturization. Next-generation technologies, such as ultrathin cameras or tiny microscopes, require...

Im Focus: Stem cell divisions in the adult brain seen for the first time

Scientists from the University of Zurich have succeeded for the first time in tracking individual stem cells and their neuronal progeny over months within the intact adult brain. This study sheds light on how new neurons are produced throughout life.

The generation of new nerve cells was once thought to taper off at the end of embryonic development. However, recent research has shown that the adult brain...

Im Focus: Interference as a new method for cooling quantum devices

Theoretical physicists propose to use negative interference to control heat flow in quantum devices. Study published in Physical Review Letters

Quantum computer parts are sensitive and need to be cooled to very low temperatures. Their tiny size makes them particularly susceptible to a temperature...

Im Focus: Autonomous 3D scanner supports individual manufacturing processes

Let’s say the armrest is broken in your vintage car. As things stand, you would need a lot of luck and persistence to find the right spare part. But in the world of Industrie 4.0 and production with batch sizes of one, you can simply scan the armrest and print it out. This is made possible by the first ever 3D scanner capable of working autonomously and in real time. The autonomous scanning system will be on display at the Hannover Messe Preview on February 6 and at the Hannover Messe proper from April 23 to 27, 2018 (Hall 6, Booth A30).

Part of the charm of vintage cars is that they stopped making them long ago, so it is special when you do see one out on the roads. If something breaks or...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

2nd International Conference on High Temperature Shape Memory Alloys (HTSMAs)

15.02.2018 | Event News

Aachen DC Grid Summit 2018

13.02.2018 | Event News

How Global Climate Policy Can Learn from the Energy Transition

12.02.2018 | Event News

 
Latest News

Fingerprints of quantum entanglement

16.02.2018 | Information Technology

'Living bandages': NUST MISIS scientists develop biocompatible anti-burn nanofibers

16.02.2018 | Health and Medicine

Hubble sees Neptune's mysterious shrinking storm

16.02.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>